Arthur P. Bollon
Director Ejecutivo en Vitruvian BioMedical, Inc. .
Cargos activos de Arthur P. Bollon
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
SignPath Pharma, Inc.
 SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT. | Director/Miembro de la Junta | 28/05/2008 | - |
| Independent Dir/Board Member | 28/05/2008 | - | |
Vitruvian BioMedical, Inc.
 Vitruvian BioMedical, Inc. Miscellaneous Commercial ServicesCommercial Services Vitruvian BioMedical, Inc. engages in the biotechnology industry. It develops and commercializes diagnostics and therapeutics for individualized and balanced healthcare with an initial focus on Alzheimer's Disease. The company was founded by Arthur P. Bollon, T. LaCarl Satcher and Rhonda R. Porterfield and is headquartered in Addison, TX. | Director Ejecutivo | 01/01/2011 | - |
| Presidente | 01/01/2011 | - | |
| Fundador | 01/01/2011 | - |
Historial de carrera de Arthur P. Bollon
Antiguos cargos conocidos de Arthur P. Bollon.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Hemobiotech, Inc.
 Hemobiotech, Inc. BiotechnologyHealth Technology HemoBioTech, Inc. is a biopharmaceutical company, that is engaged in the research and development of human blood substitute technology exclusively licensed from Texas Tech University Health Sciences Center. The company's core product, HemoTech, which is a bovine-hemoglobin based human blood substitute red blood cells in the capable of replacing human body. The company was founded in December 2003 and is headquartered in Dallas, TX. | Director Ejecutivo | 01/10/2003 | 01/08/2010 |
| Presidente | 01/10/2003 | 29/10/2009 | |
| Presidente | 01/10/2003 | 01/08/2010 | |
| Cytoclonal Pharmaceutics, Inc. | Director Ejecutivo | 01/01/1992 | 01/01/2000 |
| Presidente | 01/01/2000 | 01/01/2000 | |
| Fundador | 01/01/1992 | 01/01/2000 | |
| Presidente | - | 01/01/2000 | |
| Wadley Biosciences, Inc. | Director Ejecutivo | 01/01/1987 | 01/01/1991 |
| Presidente | 01/01/1991 | 01/01/1991 | |
| Fundador | 01/01/1991 | 01/01/1991 | |
| Presidente | - | 01/01/1991 | |
| IMMUNOTECH LABORATORIES, INC. | Director/Miembro de la Junta | 18/12/2009 | - |
| Biogress LLC | Fundador | 21/12/2009 | - |
| Corporate Officer/Principal | 01/01/2003 | 21/12/2009 |
Formación de Arthur P. Bollon.
| The Waksman Institute of Microbiology | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 9 |
Operativa
| Chief Executive Officer | 4 |
| Chairman | 4 |
| Founder | 4 |
Sectorial
| Health Technology | 4 |
| Commercial Services | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| IMMUNOTECH LABORATORIES, INC. | Health Technology |
| Empresas privadas | 6 |
|---|---|
Hemobiotech, Inc.
Hemobiotech, Inc. BiotechnologyHealth Technology HemoBioTech, Inc. is a biopharmaceutical company, that is engaged in the research and development of human blood substitute technology exclusively licensed from Texas Tech University Health Sciences Center. The company's core product, HemoTech, which is a bovine-hemoglobin based human blood substitute red blood cells in the capable of replacing human body. The company was founded in December 2003 and is headquartered in Dallas, TX. | Health Technology |
| Biogress LLC | |
SignPath Pharma, Inc.
SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT. | Commercial Services |
| Cytoclonal Pharmaceutics, Inc. | Health Technology |
| Wadley Biosciences, Inc. | |
Vitruvian BioMedical, Inc.
Vitruvian BioMedical, Inc. Miscellaneous Commercial ServicesCommercial Services Vitruvian BioMedical, Inc. engages in the biotechnology industry. It develops and commercializes diagnostics and therapeutics for individualized and balanced healthcare with an initial focus on Alzheimer's Disease. The company was founded by Arthur P. Bollon, T. LaCarl Satcher and Rhonda R. Porterfield and is headquartered in Addison, TX. | Commercial Services |
- Bolsa de valores
- Insiders
- Arthur P. Bollon
- Experiencia
